BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 10 Issue 5 Pages: e0125812 Pub: 2015 Epub: 2015 May 6 Authors Romani Vestman N , Chen T , Lif Holgerson P , Öhman C , Johansson I , |
|
|
Coexpression and secretion of endoglucanase and phytase genes in Lactobacillus reuteri. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 15 Issue 7 Pages: 12842-60 Pub: 2014 Jul 21 Epub: 2014 Jul 21 Authors Wang L , Yang Y , Cai B , Cao P , Yang M , Chen Y , |
|
|
<i>Lactobacillus reuteri</i> DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites. ✅
Go to Publication ✅
American journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol ) Vol: Issue Pages: Pub: 2019 Sep 4 Epub: 2019 Sep 4 Authors Liu Y , Tian X , He B , Hoang TK , Taylor CM , Blanchard E , Freeborn J , Park S , Luo M , Couturier J , Tran DQ , Roos S , Wu G , Rhoads JM , |
|
|
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , |
|
|
Lactobacillus reuteri Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Mice by Modulating Gut Microbiota. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 10 Issue Pages: 385 Pub: 2019 Epub: 2019 Mar 7 Authors He B , Hoang TK , Tian X , Taylor CM , Blanchard E , Luo M , Bhattacharjee MB , Freeborn J , Park S , Couturier J , Lindsey JW , Tran DQ , Rhoads JM , Liu Y , |
|
|
Probiotic Lactobacillus fermentum TSF331, Lactobacillus reuteri TSR332, and Lactobacillus plantarum TSP05 improved liver function and uric acid management-A pilot study. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 19 Issue 7 Pages: e0307181 Pub: 2024 Epub: 2024 Jul 24 Authors Lin JH , Lin CH , Kuo YW , Liao CA , Chen JF , Tsai SY , Li CM , Hsu YC , Huang YY , Hsia KC , Yeh YT , Ho HH , |
|
|
Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis. ✅
Go to Publication ✅
Life sciences (Life Sci ) Vol: 314 Issue Pages: 121309 Pub: 2023 Feb 1 Epub: 2022 Dec 20 Authors Lin C , Zheng Y , Lu J , Zhang H , Wang G , Chen W , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
